Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Biomea Fusion Inc (BMEA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biomea Fusion's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.57 -0.09    -5.42%
01/08 - Closed. Currency in USD
After Hours
1.57
-0.00
-0.00%
22:41:05 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,060,428
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.53 - 1.65
Biomea Fusion 1.57 -0.09 -5.42%

Biomea Fusion Inc Company Profile

 
Get an in-depth profile of Biomea Fusion Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

79

Equity Type

ORD

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It’s lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.

Contact Information

Address 1599 Industrial Road
San Carlos, 94070
United States
Phone 650 980 9099
Fax -

Top Executives

Name Age Since Title
Michael J. M. Hitchcock 75 2021 Interim CEO & Director
Eric M. Aguiar 63 2020 Independent Lead Director
Ramses M. Erdtmann 62 2017 Co-Founder, President, COO & Director
Elizabeth A. Faust 60 2022 Independent Director
Rohit N. Kulkarni - 2024 Member of Scientific Advisory Board
Kohjiro Ueki - 2024 Member of Scientific Advisory Board
Thomas Danne - 2024 Member of Scientific Advisory Board
Ralph A. Defronzo - 2024 Member of Scientific Advisory Board
Jeremy Pettus - 2024 Member of Scientific Advisory Board
Asma Deeb - 2024 Member of Scientific Advisory Board
Melanie Davies - 2024 Member of Scientific Advisory Board
Steven E. Kahn - - Member of Scientific Advisory Board
Pablo Aschner Montoya - 2024 Member of Scientific Advisory Board
Julio Rosenstock - 2024 Member of Scientific Advisory Board
Juliana Chan - 2024 Member of Scientific Advisory Board
Alice YY Cheng - 2024 Member of Scientific Advisory Board
Freddy Goldberg Eliaschewitz - 2024 Member of Scientific Advisory Board
Alex Abitbol - 2024 Member of Scientific Advisory Board
Steven V. Edelman 69 2024 Member of Scientific Advisory Board
Sumita Ray 51 2021 Independent Director
Julianne Averill 40 2025 Independent Director
Francesco Giorgino - 2024 Member of Scientific Advisory Board
Franco Folli - 2024 Member of Scientific Advisory Board
Linda DiMeglio - 2024 Member of Scientific Advisory Board
Desmond Schatz - 2024 Member of Scientific Advisory Board
Chantal Mathieu - 2024 Member of Scientific Advisory Board
Jay S. Skyler 78 2024 Member of Scientific Advisory Board
Mohamed Hassanein - 2024 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMEA Comments

Write your thoughts about Biomea Fusion Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email